These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 24668492)
1. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492 [TBL] [Abstract][Full Text] [Related]
2. The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34 Murone M; Radpour R; Attinger A; Chessex AV; Huguenin AL; Schürch CM; Banz Y; Sengupta S; Aguet M; Rigotti S; Bachhav Y; Massière F; Ramachandra M; McAllister A; Riether C Mol Cancer Ther; 2017 Aug; 16(8):1497-1510. PubMed ID: 28468777 [TBL] [Abstract][Full Text] [Related]
3. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism. Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047 [TBL] [Abstract][Full Text] [Related]
4. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294 [TBL] [Abstract][Full Text] [Related]
5. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Yoshimoto G; Miyamoto T; Jabbarzadeh-Tabrizi S; Iino T; Rocnik JL; Kikushige Y; Mori Y; Shima T; Iwasaki H; Takenaka K; Nagafuji K; Mizuno S; Niiro H; Gilliland GD; Akashi K Blood; 2009 Dec; 114(24):5034-43. PubMed ID: 19808698 [TBL] [Abstract][Full Text] [Related]
6. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia. Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000 [TBL] [Abstract][Full Text] [Related]
7. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. Oellerich T; Oellerich MF; Engelke M; Münch S; Mohr S; Nimz M; Hsiao HH; Corso J; Zhang J; Bohnenberger H; Berg T; Rieger MA; Wienands J; Bug G; Brandts C; Urlaub H; Serve H Blood; 2013 May; 121(19):3889-99, S1-66. PubMed ID: 23509157 [TBL] [Abstract][Full Text] [Related]
8. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558 [No Abstract] [Full Text] [Related]
9. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling. Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257 [TBL] [Abstract][Full Text] [Related]
11. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405 [TBL] [Abstract][Full Text] [Related]
12. JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML. Karjalainen R; Pemovska T; Popa M; Liu M; Javarappa KK; Majumder MM; Yadav B; Tamborero D; Tang J; Bychkov D; Kontro M; Parsons A; Suvela M; Mayoral Safont M; Porkka K; Aittokallio T; Kallioniemi O; McCormack E; Gjertsen BT; Wennerberg K; Knowles J; Heckman CA Blood; 2017 Aug; 130(6):789-802. PubMed ID: 28619982 [TBL] [Abstract][Full Text] [Related]
13. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444 [TBL] [Abstract][Full Text] [Related]
14. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells. Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437 [TBL] [Abstract][Full Text] [Related]
15. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells. Tong H; Ren Y; Zhang F; Jin J Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510 [TBL] [Abstract][Full Text] [Related]
16. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 Inhibits Cell Proliferation and Induces Markers of Cell Senescence in CD34+CD38- Leukemia Stem Cells Derived from KG1α Acute Myeloid Leukemia Cells by Activating the Sirtuin 1 (SIRT1)/Tuberous Sclerosis Complex 2 (TSC2) Signaling Pathway. Tang YL; Zhang CG; Liu H; Zhou Y; Wang YP; Li Y; Han YJ; Wang CL Med Sci Monit; 2020 Feb; 26():e918207. PubMed ID: 32037392 [TBL] [Abstract][Full Text] [Related]
18. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression. Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Li L; Osdal T; Ho Y; Chun S; McDonald T; Agarwal P; Lin A; Chu S; Qi J; Li L; Hsieh YT; Dos Santos C; Yuan H; Ha TQ; Popa M; Hovland R; Bruserud Ø; Gjertsen BT; Kuo YH; Chen W; Lain S; McCormack E; Bhatia R Cell Stem Cell; 2014 Oct; 15(4):431-446. PubMed ID: 25280219 [TBL] [Abstract][Full Text] [Related]
20. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts. Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]